Immune responses and disease biomarker long-term changes following COVID-19 mRNA vaccination in a cohort of rheumatic disease patients

Mostrar otras versiones (1)

OBJECTIVE. To evaluate seroreactivity and disease biomarkers after 2 or 3 doses of COVID-19 mRNA vaccines in a cohort of patients with rheumatic diseases. METHODS. We collected biological samples longitudinally before and after 2-3 doses of COVID-19 mRNA vaccines from a cohort of patients with syste...

Descripción completa

Detalles Bibliográficos
Autores principales: An, Zesheng, Zhou, Xian, Li, Yanfeng, Jaquith, Jane, McCarthy-Fruin, Kathleen, Sletten, Jennifer, Warrington, Kenneth J., Weyand, Cornelia, Crowson, Cynthia S., Chumsri, Saranya, Knutson, Keith L., Figueroa-Parra, Gabriel, Sanchez-Rodriguez, Alain, Thanarajasingam, Uma, Duarte-García, Alí, Zeng, Hu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10055600/
https://www.ncbi.nlm.nih.gov/pubmed/36993236
http://dx.doi.org/10.1101/2023.03.22.23287597

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10055600/
https://www.ncbi.nlm.nih.gov/pubmed/36993236
http://dx.doi.org/10.1101/2023.03.22.23287597

Ejemplares similares